332 An Alternative to Spinal Fusion for the Treatment of Degenerative Spondylolisthesis and Stenosis: Final Two-Year Analysis From a Prospective Randomized Clinical Trial Comparing Facet Arthroplasty versus Fusion
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: Previously published interim analyses from a prospective, randomized, investigation Device Exemption (IDE) clinical trial indicate that facet arthroplasty may be a viable alternative to fusion in patients with symptomatic lumbar spinal stenosis with grade I degenerative spondylolisthesis. Full two-year outcomes from the entire cohort of subjects enrolled into the IDE are needed. METHODS: Subjects, aged 35 to 80, with moderate to severe lumbar spinal stenosis and Grade I degenerative spondylolisthesis were randomly assigned (2:1) to either facet arthroplasty or to transforaminal lumbar interbody fusion (TLIF). All subjects underwent decompressive laminectomy via a mid-line incision at one lumbar level. the primary endpoint was composite clinical success at two years, which defined success as (1) the absence of reoperation or lumbar injection, (2) the absence of a major device adverse event, (3) a reduction in ODI of greater than or equal to 15 points, (4) the absence of a new or progressive neurologic deficit, and (5) the absence of fusion failure (pseudarthrosis in the fusion group or spontaneous fusion in the arthroplasty group). Subjects were considered a success only if they met all five criteria. Radiographic variables were assessed by an independent core laboratory. Secondary endpoints included VAS back and leg pain scores. RESULTS: A total of 302 subjects were randomized and treated, 207 in the facet arthroplasty group and 95 in the TLIF group. Compliance among subjects treated was high with 97.1% of the facet arthroplasty group and 94.7% of the TLIF available for assessment of the primary endpoint at two years. The arthroplasty group had a higher proportion of patients achieve composite clinical success at 24 months postoperatively than did the fusion group (79.9% vs. 28.1%; P < 0.000), equating to a between-group difference of 51.8% (95% CI 40.9% to 62.7%). the higher rate of clinical success in the arthroplasty group was driven by lower rates of fusion failure (1.6% vs. 53.6%; P < 0.000), new or progressive neurologic deficit (2.5% vs 11.9%; P = 0.0027), or failure to achieve a reduction in ODI of greater than 15 points (4.5% vs. 15.3%; P = 0.0068). Among secondary endpoints, the facet arthroplasty group reported higher mean improvement in back pain scores (55.1 vs 45.8) with a group difference of 9.3 (95% CI 17.8 to 0.8). There was no statistical difference in mean improvement in VAS leg pain scores with the facet arthroplasty group reporting mean improvement if 70.2 and the TLIF group a mean improvement of 64.3, for a group difference of 5.9 (95% CI 13.2 to -1.3). CONCLUSIONS: Final two-year outcomes from this IDE demonstrate that among properly indicated patients, facet arthroplasty is a viable alternative to fusion for the surgical management of lumbar spinal stenosis with Grade I degenerative spondylolisthesis. Continued long-term follow-up is important to validate these results and evaluate differences between facet arthroplasty and fusion.
Fields of Study & Subjects
Spine and Intervertebral Disc Pathology
Cervical and Thoracic Myelopathy
Spinal Fractures and Fixation Techniques
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 87–87
- Publication date
- 26 March 2026
- Language
- EN